Gross Profit for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's current gross profit (TTM) is $25.45B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$25.45B
YoY change
+15.4%
5Y CAGR
+7.2%
Peak year (2025)
$24.61B
Cumulative gross profit
$460.04B
Gross Profit history chart for Abbott Laboratories (ABT) from 1985 to 2025
Gross Profit history table for Abbott Laboratories (ABT) from 1985 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $24.61B | +15.4% | ||
| 2024 | $21.32B | +6.4% | ||
| 2023 | $20.04B | -10.2% | ||
| 2022 | $22.32B | -3.8% | ||
| 2021 | $23.21B | +33.6% | ||
| 2020 | $17.38B | +4.1% | ||
| 2019 | $16.69B | +5.5% | ||
| 2018 | $15.82B | +21.1% | ||
| 2017 | $13.07B | +16.2% | ||
| 2016 | $11.24B | +2.6% | ||
| 2015 | $10.96B | +4.5% | ||
| 2014 | $10.49B | +6.4% | ||
| 2013 | $9.86B | -9.2% | ||
| 2012 | $10.85B | -53.7% | ||
| 2011 | $23.44B | +13.8% | ||
| 2010 | $20.59B | +16.9% | ||
| 2009 | $17.62B | +3.4% | ||
| 2008 | $17.04B | +16.9% | ||
| 2007 | $14.59B | +13.6% | ||
| 2006 | $12.84B | +8.2% | ||
| 2005 | $11.87B | +10.0% | ||
| 2004 | $10.80B | +5.8% | ||
| 2003 | $10.21B | +11.2% | ||
| 2002 | $9.18B | +7.5% | ||
| 2001 | $8.54B | +13.7% | ||
| 2000 | $7.51B | +4.3% | ||
| 1999 | $7.20B | +1.7% | ||
| 1998 | $7.08B | +3.6% | ||
| 1997 | $6.84B | +8.9% | ||
| 1996 | $6.28B | +10.5% | ||
| 1995 | $5.69B | +10.2% | ||
| 1994 | $5.16B | +9.3% | ||
| 1993 | $4.72B | -1.1% | ||
| 1992 | $4.77B | +16.0% | ||
| 1991 | $4.12B | +14.2% | ||
| 1990 | $3.60B | +15.1% | ||
| 1989 | $3.13B | +9.7% | ||
| 1988 | $2.85B | +12.8% | ||
| 1987 | $2.53B | +18.3% | ||
| 1986 | $2.14B | +17.4% | ||
| 1985 | $1.82B | — |
Gross Profit values are taken from Abbott Laboratories's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual gross profit for Abbott Laboratories (ABT) came in at $24.61B – grew 15.4% year-over-year.
Through 2020–2025 (5 years), Abbott Laboratories gross profit delivered a +7.2% annualised rate; sustaining 2 straight years of year-over-year growth.
The highest annual gross profit of $24.61B was reported in 2025. The lowest in the available history was $1.82B in 1985.
Abbott Laboratories (ABT) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $53.80B.
Abbott Laboratories Gross Profit by Year
Abbott Laboratories Gross Profit 2025: $24.61B
Abbott Laboratories gross profit in 2025 was $24.61B, grew 15.4% from 2024. This figure represents the highest annual value in the available history.
Abbott Laboratories Gross Profit 2024: $21.32B
Abbott Laboratories gross profit in 2024 was $21.32B, grew 6.4% from 2023.
Abbott Laboratories Gross Profit 2023: $20.04B
Abbott Laboratories gross profit in 2023 was $20.04B, declined 10.2% below 2022.
Abbott Laboratories Gross Profit 2022: $22.32B
Abbott Laboratories gross profit in 2022 was $22.32B, edged down 3.8% below 2021.
Abbott Laboratories Gross Profit 2021: $23.21B
Abbott Laboratories gross profit in 2021 was $23.21B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Gross Profit
Companies in the same sector as Abbott Laboratories, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's gross profit?
- Latest reported gross profit for Abbott Laboratories (ABT) is $25.45B (period ending March 31, 2026).
How has Abbott Laboratories gross profit changed year-over-year?
- Abbott Laboratories (ABT) gross profit changed +15.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories gross profit?
- Abbott Laboratories (ABT) gross profit compound annual growth rate is +7.2% over the most recent 5 years available.
When did Abbott Laboratories gross profit hit its highest annual value?
- Abbott Laboratories gross profit reached its highest annual value of $24.61B in 2025.
What was Abbott Laboratories gross profit in 2024?
- Abbott Laboratories (ABT) gross profit in 2024 was $21.32B.
What was Abbott Laboratories gross profit in 2025?
- Abbott Laboratories (ABT) gross profit in 2025 was $24.61B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.